Cannabis Stocks Slide During FDA Hearing On CBD



Major cannabis companies traded lower Friday during a Food and Drug Administration hearing on CBD products. The cannabis industry has been in a legal haze as the FDA decides how to police products with CBD. Wall Street thinks the $1 billion CBD industry could grow to $16 billion depending on how it’s regulated. Visit Market Insider’s homepage for more stories. Cannabis stocks traded lower Friday during a hearing held by the Food and Drug Administration where federal regulators will hear arguments that will inform policing of the substance cannabidiol, or CBD.
https://www.businessinsider.com/weed-cannabis-stocks-slip-during-fda-hearing-on-cbd-products-2019-5

This video was produced by YT Wochit News using http://wochit.com

source

%d bloggers like this: